1 |
Swadźba J, Anyszek T, Panek A, Chojęta A, Piotrowska-Mietelska A, Martin E. The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration. Vaccines (Basel) 2023;11. [PMID: 36851157 DOI: 10.3390/vaccines11020278] [Reference Citation Analysis]
|
2 |
Cimas FJ, Torres J, Ontañón J, de Cabo C, Lozano J, Requena MÁ, Blas J, Rodríguez-García JL, Mas A, Solera J. Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination. Front Immunol 2023;14:1097747. [PMID: 36776854 DOI: 10.3389/fimmu.2023.1097747] [Reference Citation Analysis]
|
3 |
Pascucci D, Grossi A, Lontano A, Marziali E, Nurchis MC, Grassi VM, Raponi M, Vetrugno G, Capelli G, Calabrò GE, Staiti D, Sanguinetti M, Damiani G, Laurenti P. Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study. Vaccines (Basel) 2022;11. [PMID: 36679868 DOI: 10.3390/vaccines11010025] [Reference Citation Analysis]
|
4 |
Fernandes-Siqueira LO, Sousa BG, Cleto CE, Wermelinger LS, Caetano BLL, Pacheco AR, Costa SM, Almeida FCL, Ferreira GC, Salmon D, Alves AMB, Da Poian AT. IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2. J Clin Virol Plus 2022;2:100121. [PMID: 36349309 DOI: 10.1016/j.jcvp.2022.100121] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Torres J, Ontañón J, de Cabo C, Lozano J, Ángeles Requena M, Blas J, Rodríguez-garcía JL, Mas A, Cimas FJ, Solera J. Mathematical modeling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination.. [DOI: 10.1101/2022.08.15.22278583] [Reference Citation Analysis]
|